Search results for "comorbid"

showing 10 items of 827 documents

Relevance of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) On Non-Relapse Related Mortality (NRM) in Patients with Acute…

2009

Abstract Abstract 3352 Poster Board III-240 Allogeneic HSCT is established as a potent curative therapy in adult patients with high risk ALL. However, due to transplant-related morbidity and lethality the gains in relapse prevention do not necessarily translate into survival advantages in the overall patient population. Defining the role of allogeneic HSCT in ALL patients in first complete remission (CR1) according to leukemia related risk factors, to transplant related risk factors (e.g. HLA matching, conditioning therapy and immunosuppressive treatment), and to comorbidity related risks, remains a major task for upcoming clinical trials. Several retrospective studies suggest that the HCT-…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentImmunologyRetrospective cohort studyCell BiologyHematologyHematopoietic stem cell transplantationTotal body irradiationmedicine.diseaseBiochemistryComorbidityFludarabineSurgeryTransplantationhemic and lymphatic diseasesInternal medicinemedicineCumulative incidenceProspective cohort studybusinessmedicine.drugBlood
researchProduct

2013

A current model suggested that the somatic symptom dimension accounts for the adverse effect of depression in patients with coronary heart disease (CHD). In order to test this model we sought to determine in a large population-based sample how symptom dimensions of depression are associated with CHD, biomarkers and traditional risk factors. The associations of cognitive and somatic symptom dimensions of depression with CHD, risk factors, endothelial function, and biomarkers of inflammation and myocardial stress were analyzed cross-sectionally in a sample of n=5000 Mid-Europeans aged 35–74 years from the Gutenberg Health Study (GHS). Only the somatic symptom dimension of depression was assoc…

medicine.medical_specialtyeducation.field_of_studyMultidisciplinarybusiness.industryCross-sectional studyPopulationmedicine.diseaseComorbidityInternal medicineMedicineMyocardial infarctionFamily historybusinesseducationAdverse effectPsychiatryDyslipidemiaDepression (differential diagnoses)PLOS ONE
researchProduct

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study

2020

INTRODUCTION Coronavirus disease 2019 (COVID-19) caused by SARS-CoV2 virus is thought to be more severe in patients with prior hematological diseases. There is evidence suggesting that hematological patients are particularly vulnerable and have a higher risk of developing severe events, with higher mortality rate than general population. However, the available data are limited, and prognostic factors at admission still remain unclear. With this background, our aims were to analyze the impact of hematological diseases and their therapy on the COVID-19 severity and to identify clinical and biological risk factors to predict the outcome in these patients. METHODS We carried out a multicenter …

medicine.medical_specialtyeducation.field_of_studybusiness.industryMortality rateImmunologyPopulation203.Lymphocytes Lymphocyte Activation and Immunodeficiency including HIV and Other InfectionsRetrospective cohort studyCell BiologyHematologyDiseasemedicine.diseaseBiochemistryComorbidityMulticenter studyInternal medicineIntensive caremedicineIn patienteducationbusinessBlood
researchProduct

SP0088 New drugs, but still comorbidity

2017

As the population ages the simultaneous presence of multiple pathological conditions in the form of comorbidity and multimorbidity is more a rule than an exception. Comorbidity is reported in 35 to 80% of all ill people (Taylor et al. 2010). Comorbidity and multimorbidity are challenging researchers, clinicians and policy makers as these persons require more frequent appointments and hospitalizations and are at a greater risk for drug interactions, disability and mortality (Slater 2011). Although numerous chronic disease prevention strategies and treatment guidelines have been developed, they mainly address single conditions and ignore the presence of co-existing conditions (van der Noyen 2…

medicine.medical_specialtyeducation.field_of_studybusiness.industryPublic healthPopulationArthritisPhysical exercisemedicine.diseaseComorbidityRheumatologyRheumatoid arthritisInternal medicinemedicineBack painPhysical therapymedicine.symptombusinesseducationSpeaker Presentations
researchProduct

Impact of Non-Alcoholic Fatty Liver Disease on Metabolic Comorbidities in Type 2 Diabetes Mellitus.

2021

Abstract Objective Type 2 Diabetes (T2D) is a major risk factor for the development and progression of non-alcoholic fatty liver disease (NAFLD). The published prevelance in epidemiological studies in this high risk population exceeds 70%. The aim of this analysis was to investigate the impact of NAFLD on T2D patients in Germany. Methods Using the Disease Analyzer Database (IQVIA), T2D patients with NAFLD diagnosed in Germany were matched to a cohort without NAFLD controlling for age, sex, physician, index year and metabolic comorbidities and assessed for their risk of developing myocardial infarction, stroke, peripheral arterial disease (PAD) or chronic kidney disease, as well as the type …

medicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismPopulationType 2 diabetesComorbidity03 medical and health sciencesLiver disease0302 clinical medicineEndocrinologyNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineEpidemiologyInternal MedicinemedicineHumansInsulinRisk factoreducationeducation.field_of_studybusiness.industryFatty livernutritional and metabolic diseasesType 2 Diabetes MellitusGeneral Medicinemedicine.diseasedigestive system diseasesDiabetes Mellitus Type 2030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessKidney diseaseExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Eclectic Ocular Comorbidities and Systemic Diseases with Eye Involvement: A Review.

2016

Coexistence of several ocular diseases is more frequent than suspected. In spite of the refractive errors, one or more of the following can be detected simultaneously: glaucoma, cataracts, uveitis, age-related macular degeneration, and dry eyes. In addition, as people age, ocular comorbidities are much more usually seen. Specific diseases are openly acknowledged to affect the eyes and vision, such as diabetes mellitus, hypertension blood pressure, arthritis, hyperthyroidism, neurodegenerative disorders, hematologic malignancies, and/or systemic infections. Recent advances in early diagnosis and therapy of the ophthalmic pathologies have reinforced patient options to prevent visual impairmen…

medicine.medical_specialtygenetic structuresVisual impairmentGlaucomalcsh:MedicineContext (language use)Review ArticleGeneral Biochemistry Genetics and Molecular Biologycomorbidity; humans; eye diseases03 medical and health sciences0302 clinical medicineCataractsDiabetes mellitusmedicineIntensive care medicinehumansGeneral Immunology and Microbiologybusiness.industrySettore MED/30 - Malattie Apparato Visivolcsh:Reye diseasesGeneral MedicineMacular degenerationmedicine.diseaseComorbidityeye diseasescomorbidity030221 ophthalmology & optometryPhysical therapysense organsmedicine.symptombusiness030217 neurology & neurosurgeryUveitis
researchProduct

Visual Impairment Is Associated With Depressive Symptoms—Results From the Nationwide German DEGS1 Study

2018

Introduction: Visual impairment is associated with a variety of co-morbidities including physical and mental health in industrial countries. Our aim is to examine associations between self-reported impairment and depressive symptoms in the German population. Methods: The point prevalence of self-reported visual impairment in Germany was computed using data from the German Health Interview and Examination Survey for adults from 2008 to 2011 (N=7.783, 50.5% female, age range 18-79 years). Visual impairment was surveyed by two questions, one for seeing faces at a distance of 4 meters and one for reading newspapers. Depressive symptoms were evaluated with the PHQ-9 questionnaire and two-week pr…

medicine.medical_specialtygenetic structureslcsh:RC435-571Visual impairmentPopulationPrevalencevisual impairmentLogistic regressionPatient Health Questionnaire-903 medical and health sciences0302 clinical medicinedepressive symptomsreadinglcsh:PsychiatryEpidemiologyMedicine030212 general & internal medicineeducationDepression (differential diagnoses)Original ResearchPsychiatryeducation.field_of_studybusiness.industryConfoundingmedicine.diseaseComorbidityPsychiatry and Mental health030221 ophthalmology & optometryepidemiologymedicine.symptombusinessClinical psychologyface recognitionFrontiers in Psychiatry
researchProduct

Cardiac arrest in older adult patients

2021

Purpose of review To describe the epidemiology, prognostication, and treatment of out- and in-hospital cardiac arrest (OHCA and IHCA) in elderly patients. Recent findings Elderly patients undergoing cardiac arrest (CA) challenge the appropriateness of attempting cardiopulmonary resuscitation (CPR). Current literature suggests that factors traditionally associated with survival to hospital discharge and neurologically intact survival after CA cardiac arrest in general (e.g. presenting ryhthm, bystander CPR, targeted temperature management) may not be similarly favorable in elderly patients. Alternative factors meaningful for outcome in this special population include prearrest functional sta…

medicine.medical_specialtyhealth care facilities manpower and servicesmedicine.medical_treatmentMEDLINE030204 cardiovascular system & hematologyTargeted temperature management03 medical and health sciences0302 clinical medicineHypothermia InducedEpidemiologyMedicineHumansCardiopulmonary resuscitationAgedResuscitation OrdersAged 80 and overAdult patientsbusiness.industry030208 emergency & critical care medicinemedicine.diseaseComorbidityhumanitiesCardiopulmonary ResuscitationHeart ArrestAnesthesiology and Pain MedicineEmergency medicineFunctional statusRisk classificationbusinessOut-of-Hospital Cardiac Arrest
researchProduct

Cardiovascular Implantable Electronic Device Infection and New Insights About Correlation Between Pro-inflammatory Markers and Heart Failure: A Syste…

2021

Introduction: Surgical approaches to treat patients with abnormal pro-inflammatory parameters remain controversial, and the debate on the correlation between hematological parameter alteration in cardiac implantable electronic device (CIED) infection and the increase in mortality continues.Methods: We performed a systematic review using the PubMed, Scopus, and Cochrane Library databases. Twenty-two articles from May 2007 to April 2020 were selected and divided according to the following topics: prevalence of microbes in patients with CIED infection; characteristics of patients with CIED infection; comparison between patients who underwent and did not undergo replantation after device extrac…

medicine.medical_specialtyheart failure030204 cardiovascular system & hematologyCochrane LibraryCardiovascular Medicine03 medical and health sciences0302 clinical medicineSettore MED/43 - Medicina LegaleWhite blood cellInternal medicineEpidemiologymedicineDiseases of the circulatory (Cardiovascular) systemrisk factors030212 general & internal medicineLeukocytosisCIED infectionbusiness.industrymicrobiologyRed blood cell distribution widthmedicine.diseaseinflammatory markersComorbiditymedicine.anatomical_structureHeart failureMeta-analysisRC666-701cardiac infection CED infimammatorySystematic Reviewmedicine.symptomCardiology and Cardiovascular MedicinebusinessFrontiers in Cardiovascular Medicine
researchProduct

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction.

2018

Objective: To assess the effects of comorbidities, fragility, and quality of life (QOL) on long-term prognosis in ambulatory patients with heart failure (HF) with midrange left ventricular ejection fraction (HFmrEF), an unexplored area. Patients and Methods: Consecutive patients prospectively evaluated at an HF clinic between August 1, 2001, and December 31, 2015, were retrospectively analyzed on the basis of left ventricular ejection fraction category. We compared patients with HFmrEF (n=185) to those with reduced (HFrEF; n=1058) and preserved (HFpEF; n=162) ejection fraction. Fragility was defined as 1 or more abnormal evaluations on 4 standardized geriatric scales (Barthel Index, Older A…

medicine.medical_specialtylcsh:R5-920Ejection fractionbusiness.industryDepression scaleComorbidity score030204 cardiovascular system & hematologymedicine.disease03 medical and health sciences0302 clinical medicineFragilityQuality of lifeHeart failureInternal medicineAmbulatoryCardiologyMedicineGeriatric Depression Scale030212 general & internal medicinebusinesslcsh:Medicine (General)Mayo Clinic proceedings. Innovations, qualityoutcomes
researchProduct